BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25123036)

  • 1. KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients.
    Alexopoulou DK; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
    Biomark Med; 2014; 8(5):671-85. PubMed ID: 25123036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.
    Christodoulou S; Alexopoulou DK; Kontos CK; Scorilas A; Papadopoulos IN
    Tumour Biol; 2014 May; 35(5):4673-85. PubMed ID: 24430362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kallikrein-related peptidase 4 (KLK4) mRNA predicts short-term relapse in colorectal adenocarcinoma patients.
    Kontos CK; Chantzis D; Papadopoulos IN; Scorilas A
    Cancer Lett; 2013 Mar; 330(1):106-12. PubMed ID: 23201139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
    Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
    J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma.
    Foteinou E; Kontos CK; Giotakis AI; Scorilas A
    Biol Chem; 2014 Sep; 395(9):1051-62. PubMed ID: 24854539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic significance of human kallikrein 11 (KLK11) mRNA expression levels in patients with laryngeal cancer.
    Patsis C; Yiotakis I; Scorilas A
    Clin Biochem; 2012 Jun; 45(9):623-30. PubMed ID: 22429520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.
    Ogawa K; Utsunomiya T; Mimori K; Tanaka F; Inoue H; Nagahara H; Murayama S; Mori M
    Clin Cancer Res; 2005 Apr; 11(8):2889-93. PubMed ID: 15837738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
    Alexopoulou DK; Papadopoulos IN; Scorilas A
    Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value.
    Rapti SM; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
    Clin Biochem; 2017 Nov; 50(16-17):918-924. PubMed ID: 28624481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of HOXB8 and KLK11 expression levels as potential biomarkers to predict the effects of FOLFOX4 chemotherapy.
    Li S; Lu X; Chi P; Pan J
    Future Oncol; 2013 May; 9(5):727-36. PubMed ID: 23647300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
    Alqurashi N; Gopalan V; Smith RA; Lam AK
    Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic role of p53 messenger ribonucleic acid expression in patients after curative resection for stage I to III colorectal cancer: association with colon cancer stem cell markers.
    Huh JW; Kim HR; Kim YJ
    J Am Coll Surg; 2013 Jun; 216(6):1063-9. PubMed ID: 23571142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and single nucleotide polymorphisms of kallikrein 10 in colorectal cancer].
    Feng B; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Qu Y; Li JW; Lu AG; Wang ML; Liu BY; Zhu ZG
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):623-7. PubMed ID: 16784657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer.
    Okugawa Y; Inoue Y; Tanaka K; Toiyama Y; Shimura T; Okigami M; Kawamoto A; Hiro J; Saigusa S; Mohri Y; Uchida K; Kusunoki M
    Oncol Rep; 2013 Sep; 30(3):1449-54. PubMed ID: 23784200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer.
    Shigemasa K; Gu L; Tanimoto H; O'Brien TJ; Ohama K
    Clin Cancer Res; 2004 Apr; 10(8):2766-70. PubMed ID: 15102682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients.
    Diamantopoulos MA; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
    Clin Chem Lab Med; 2017 May; 55(5):737-747. PubMed ID: 27930363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
    Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
    Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein beta 3 (HSPB3) is an unfavorable molecular biomarker in colorectal adenocarcinoma.
    Kalioraki MA; Artemaki PI; Sklirou AD; Kontos CK; Adamopoulos PG; Papadopoulos IN; Trougakos IP; Scorilas A
    Mol Carcinog; 2020 Jan; 59(1):116-125. PubMed ID: 31709619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of upregulated DR-nm23 expression on invasion and metastasis in colorectal cancer.
    Qu L; Liang L; Su J; Yang Z
    Eur J Cancer Prev; 2013 Nov; 22(6):512-22. PubMed ID: 23765094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.